Morse Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,872
Closed -$1.68M 147
2019
Q3
$1.68M Sell
16,872
-9,250
-35% -$879K 0.63% 50
2019
Q2
$2.42M Sell
26,122
-2,068
-7% -$196K 0.71% 39
2019
Q1
$2.66M Sell
28,190
-10,250
-27% -$896K 0.8% 37
2018
Q4
$2.46M Sell
38,440
-100
-0.3% -$7.38K 0.87% 36
2018
Q3
$3.45M Buy
38,540
+100
+0.3% +$8.84K 0.91% 33
2018
Q2
$3.05M Sell
38,440
-2,500
-6% -$208K 0.84% 38
2018
Q1
$3.65M Sell
40,940
-9,045
-18% -$868K 1.01% 30
2017
Q4
$5.22M Sell
49,985
-11,625
-19% -$1.31M 1.45% 20
2017
Q3
$8.98M Buy
61,610
+1,550
+3% +$211K 2.68% 6
2017
Q2
$7.8M Sell
60,060
-2,390
-4% -$293K 2.54% 6
2017
Q1
$7.77M Buy
+62,450
New +$7.47M 2.65% 6

Other funds holding CELG

Morse Asset Management's CELG Position: Q4 2019 in Review

Morse Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,872 shares — an estimated $1.68M sold.

Morse Asset Management first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $8.98M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Morse Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Morse Asset Management sold 16,872 Celgene Corp shares in Q4 2019, an estimated $1.68M.
  • Morse Asset Management first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Morse Asset Management's Celgene Corp position peaked at $8.98M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Morse Asset Management's 13F filing for Q4 2019, filed 31 Jan 2020.